214 related articles for article (PubMed ID: 19545735)
1. Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation.
Verleden GM; Lievens Y; Dupont LJ; Van Raemdonck DE; De Vleeschauwer SI; Vos R; Vanaudenaerde BM
Transplant Proc; 2009 Jun; 41(5):1816-20. PubMed ID: 19545735
[TBL] [Abstract][Full Text] [Related]
2. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.
Yates B; Murphy DM; Forrest IA; Ward C; Rutherford RM; Fisher AJ; Lordan JL; Dark JH; Corris PA
Am J Respir Crit Care Med; 2005 Sep; 172(6):772-5. PubMed ID: 15976371
[TBL] [Abstract][Full Text] [Related]
5. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
[TBL] [Abstract][Full Text] [Related]
6. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
[TBL] [Abstract][Full Text] [Related]
7. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.
Vos R; Vanaudenaerde BM; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Van Raemdonck DE; Schoonis A; Nawrot TS; Dupont LJ; Verleden GM
Eur Respir J; 2011 Jan; 37(1):164-72. PubMed ID: 20562124
[TBL] [Abstract][Full Text] [Related]
9. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
Kingah PL; Muma G; Soubani A
Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
[TBL] [Abstract][Full Text] [Related]
13. Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation: a single-center experience and review of literature.
Lebeer M; Kaes J; Lambrech M; Vanstapel A; Beeckmans H; Ambrocio GPL; Vanaudenaerde BM; Verleden SE; Verbeken EK; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verleden GM; Vos R;
Transpl Int; 2020 Feb; 33(2):216-228. PubMed ID: 31643104
[TBL] [Abstract][Full Text] [Related]
14. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation.
Diamond DA; Michalski JM; Lynch JP; Trulock EP
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):795-800. PubMed ID: 9652840
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
17. Long-term clarithromycin therapy in the management of lung transplant recipients.
Benden C; Boehler A
Transplantation; 2009 May; 87(10):1538-40. PubMed ID: 19461491
[TBL] [Abstract][Full Text] [Related]
18. [Azithromycin as a novel treatment for bronchiolitis obliterans syndrome].
Peled N; Shitrit D; Bendayan D; Kramer MR
Harefuah; 2007 Mar; 146(3):219-22, 245. PubMed ID: 17460931
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation.
Fisher AJ; Rutherford RM; Bozzino J; Parry G; Dark JH; Corris PA
Am J Transplant; 2005 Mar; 5(3):537-43. PubMed ID: 15707408
[TBL] [Abstract][Full Text] [Related]
20. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT--a randomized double-blinded placebo-controlled study.
Lam DC; Lam B; Wong MK; Lu C; Au WY; Tse EW; Leung AY; Kwong YL; Liang RH; Lam WK; Ip MS; Lie AK
Bone Marrow Transplant; 2011 Dec; 46(12):1551-6. PubMed ID: 21317934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]